Temporary increase in body temperature from heightened metabolic activity
Hair loss concerns A growing concern among tirzepatide users involves GLP-1 related hair loss
Research Dosing Protocols in Practice Published research studies using Dihexa have employed a remarkably wide range of administration frequencies, reflecting both different research objectives and evolving understanding of the compound's optimal use
Tendon healing In a rat model in the Journal of Applied Physiology , BPC-157 accelerated tendon healing by promoting tendon-cell outgrowth, cell survival and cell migration, which the authors linked to the VEGF and nitric-oxide pathways [2]
VIP delivery challenges The main limitation of VIP as a therapeutic peptide is its extremely short plasma half-life
A 2025 systematic review identified 544 total articles on BPC-157 published between 1993 and 2024, but after applying inclusion criteria, only 36 studies remained eligible for analysis